David Clair | Vice President-Investor Relations |
Chuck Kummeth | Chief Executive Officer |
Jim Hippel | Chief Financial Officer |
Will Geist | President-Protein Sciences Segment |
Puneet Souda | Leerink Partners |
Patrick Donnelly | Citi |
Jacob Johnson | Stephens |
Dan Arias | Stifel |
Dan Leonard | Credit Suisse |
Catherine Schulte | Baird |
Good morning, and welcome to the Bio-Techne Earnings Conference Call for the Fourth Quarter of Fiscal Year 2023. At this time all participants have been placed in listen-only mode and the call will be opened for questions following management's prepared remarks.
During our Q&A session, please limit yourself to one question and a follow up.
I would now like to turn the call over to David Clair, Bio-Techne's Vice President, Investor Relations.
Good morning and thank you for joining us.